caffeine has been researched along with Preterm Birth in 33 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of occipital nerve block compared with standard care , defined as acetaminophen with caffeine, for treatment of acute headache in pregnancy." | 9.69 | Occipital Nerve Block Compared With Acetaminophen and Caffeine for Headache Treatment in Pregnancy: A Randomized Controlled Trial. ( Blanchard, CT; Bushman, ET; Casey, BM; Cozzi, GD; Davis, AM; Digre, KB; Harper, L; Jones, B; Robbins, LS; Sinkey, RG; Szychowski, JM; Tita, AT, 2023) |
| "The substantial majority finding from observational studies and meta-analyses is that maternal caffeine consumption is reliably associated with major negative pregnancy outcomes." | 9.12 | Maternal caffeine consumption and pregnancy outcomes: a narrative review with implications for advice to mothers and mothers-to-be. ( James, JE, 2021) |
| "There is insufficient evidence to confirm or refute the effectiveness of caffeine avoidance on birthweight or other pregnancy outcomes." | 8.91 | Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes. ( Jaafar, SH; Jahanfar, S, 2015) |
| "Caffeine is commonly consumed during pregnancy, crosses the placenta, with fetal serum concentrations similar to the mother's, but studies of birth outcome show conflicting findings." | 8.90 | Caffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose-response meta-analysis. ( Cade, JE; Garrard, L; Greenwood, DC; Keogh, G; King, LG; Thatcher, NJ; Ye, J, 2014) |
| "In this meta-analysis, we observed no important association between caffeine intake during pregnancy and the risk of preterm birth for cohort and case-control studies." | 8.86 | Caffeine consumption during pregnancy and risk of preterm birth: a meta-analysis. ( Bhattacharya, S; Lin, SW; Maslova, E; Michels, KB, 2010) |
| "Few previous studies have investigated the association between prenatal caffeine intake and birth size (small for gestational age [SGA], preterm birth, and birthweight Z-score) in Japan." | 7.91 | Dose-dependent associations between prenatal caffeine consumption and small for gestational age, preterm birth, and reduced birthweight in the Japan Environment and Children's Study. ( Ait Bamai, Y; Araki, A; Itoh, S; Kishi, R; Kobayashi, S; Minatoya, M; Miyashita, C; Murata, K; Saijo, Y; Sata, F; Yamazaki, K, 2019) |
| " To describe caffeine consumption during pregnancy and its association with low birth weight (LBW) and preterm birth in the birth cohort of Ribeirão Preto, state of São Paulo, Brazil, in 2010." | 7.88 | Association between Caffeine Consumption in Pregnancy and Low Birth Weight and Preterm Birth in the birth Cohort of Ribeirão Preto. ( Batista, RFL; Cardoso, VC; Cavalli, RC; Grandi, C; Simões, VMF; Vitti, FP, 2018) |
| "Objetive: identify whether there is an increased risk of adverse perinatal outcomes, like prematurity or decreased weight in newborns, associated with caffeine consumption during the first half of pregnancy in pregnant women of our population." | 7.81 | PERINATAL OUTCOMES OF PREMATURITY AND BIRTH WEIGHT ACCORDING TO MATERNAL CAFFEINE CONSUMPTION. ( Bueno-Cavanillas, A; Del Castillo, N; Jiménez-Moleón, JJ; Martínez-Ruiz, V; Mozas, J; Olmedo-Requena, R, 2015) |
| "Estimation of the maternal caffeine intake during pregnancy and its influence on pregnancy duration, birthweight and Apgar score of the newborn." | 7.78 | Maternal caffeine intake and its effect on pregnancy outcomes. ( Jarosz, M; Siuba, M; Wierzejska, R, 2012) |
| "Moderate caffeine consumption (less than 200 mg per day) does not appear to be a major contributing factor in miscarriage or preterm birth." | 7.76 | ACOG CommitteeOpinion No. 462: Moderate caffeine consumption during pregnancy. ( , 2010) |
| "To evaluate the efficacy of occipital nerve block compared with standard care , defined as acetaminophen with caffeine, for treatment of acute headache in pregnancy." | 5.69 | Occipital Nerve Block Compared With Acetaminophen and Caffeine for Headache Treatment in Pregnancy: A Randomized Controlled Trial. ( Blanchard, CT; Bushman, ET; Casey, BM; Cozzi, GD; Davis, AM; Digre, KB; Harper, L; Jones, B; Robbins, LS; Sinkey, RG; Szychowski, JM; Tita, AT, 2023) |
| "To examine 5-year outcomes in children enrolled in a pilot randomized controlled trial of a high loading dose of caffeine after preterm birth." | 5.51 | Five-year outcomes of premature infants randomized to high or standard loading dose caffeine. ( Cyr, PEP; Inder, TE; Lean, RE; McPherson, C; Rogers, CE; Smyser, CD, 2022) |
| "Caffeine was prescribed for apnea of prematurity and caffeine exposure was determined by chart review." | 5.51 | Caffeine exposure and acute kidney injury in premature infants with necrotizing enterocolitis and spontaneous intestinal perforation. ( Aviles-Otero, N; Carmody, JB; Green, G; Khalsa, DD; Kumar, R, 2019) |
| "Caffeine exposure was associated to SGA (OR = 1." | 5.51 | Caffeine exposure during pregnancy, small for gestational age birth and neonatal outcome - results from the Norwegian Mother and Child Cohort Study. ( Bellocco, R; Brantsæter, AL; Elfvin, A; Jacobsson, B; Meltzer, HM; Modzelewska, D; Sengpiel, V, 2019) |
| "Caffeine intake was consistently associated with decreased BW and increased odds of SGA." | 5.39 | Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study. ( Alexander, J; Bacelis, J; Brantsaeter, AL; Elind, E; Grove, J; Haugen, M; Jacobsson, B; Meltzer, HM; Myhre, R; Nilsson, S; Sengpiel, V, 2013) |
| " Among them, magnesium sulfate, given antenatally to pregnant women with imminent preterm birth before 30 to 34 weeks of gestation, as well as caffeine administered to preterm infants after birth, exhibited neuroprotective effects for human preterm brain." | 5.22 | Pharmacological Neuroprotection of the Preterm Brain: Current Evidence and Perspectives. ( Siahanidou, T; Spiliopoulou, C, 2022) |
| "The substantial majority finding from observational studies and meta-analyses is that maternal caffeine consumption is reliably associated with major negative pregnancy outcomes." | 5.12 | Maternal caffeine consumption and pregnancy outcomes: a narrative review with implications for advice to mothers and mothers-to-be. ( James, JE, 2021) |
| " EBPCS is defined as the management of the VPIs during the perinatal period which would include antenatal counseling with team briefing and share decision making, treat the chorioamnionitis, antenatal MgS04, antenatal steroid, delayed cord clamping/milking, neonatal resuscitation team preparation, prevention of hypothermia, immediate respiratory support with continuous positive airway pressure at delivery room, less invasive surfactant administration, early surfactant with budesonide therapy, support of cardiovascular system, early initiate of probiotics administration, early caffeine, early parenteral and enteral nutrition, promptly initiating antibiotics." | 5.05 | Evidence base multi-discipline critical strategies toward better tomorrow for very preterm infants. ( Chen, YT; Chiu, HY; Chu, SM; Lin, HC; Lin, HY; Tsai, ML, 2020) |
| "There is insufficient evidence to confirm or refute the effectiveness of caffeine avoidance on birthweight or other pregnancy outcomes." | 4.91 | Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes. ( Jaafar, SH; Jahanfar, S, 2015) |
| "Caffeine is commonly consumed during pregnancy, crosses the placenta, with fetal serum concentrations similar to the mother's, but studies of birth outcome show conflicting findings." | 4.90 | Caffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose-response meta-analysis. ( Cade, JE; Garrard, L; Greenwood, DC; Keogh, G; King, LG; Thatcher, NJ; Ye, J, 2014) |
| "In this meta-analysis, we observed no important association between caffeine intake during pregnancy and the risk of preterm birth for cohort and case-control studies." | 4.86 | Caffeine consumption during pregnancy and risk of preterm birth: a meta-analysis. ( Bhattacharya, S; Lin, SW; Maslova, E; Michels, KB, 2010) |
| "Few previous studies have investigated the association between prenatal caffeine intake and birth size (small for gestational age [SGA], preterm birth, and birthweight Z-score) in Japan." | 3.91 | Dose-dependent associations between prenatal caffeine consumption and small for gestational age, preterm birth, and reduced birthweight in the Japan Environment and Children's Study. ( Ait Bamai, Y; Araki, A; Itoh, S; Kishi, R; Kobayashi, S; Minatoya, M; Miyashita, C; Murata, K; Saijo, Y; Sata, F; Yamazaki, K, 2019) |
| " To describe caffeine consumption during pregnancy and its association with low birth weight (LBW) and preterm birth in the birth cohort of Ribeirão Preto, state of São Paulo, Brazil, in 2010." | 3.88 | Association between Caffeine Consumption in Pregnancy and Low Birth Weight and Preterm Birth in the birth Cohort of Ribeirão Preto. ( Batista, RFL; Cardoso, VC; Cavalli, RC; Grandi, C; Simões, VMF; Vitti, FP, 2018) |
| "Objetive: identify whether there is an increased risk of adverse perinatal outcomes, like prematurity or decreased weight in newborns, associated with caffeine consumption during the first half of pregnancy in pregnant women of our population." | 3.81 | PERINATAL OUTCOMES OF PREMATURITY AND BIRTH WEIGHT ACCORDING TO MATERNAL CAFFEINE CONSUMPTION. ( Bueno-Cavanillas, A; Del Castillo, N; Jiménez-Moleón, JJ; Martínez-Ruiz, V; Mozas, J; Olmedo-Requena, R, 2015) |
| "Estimation of the maternal caffeine intake during pregnancy and its influence on pregnancy duration, birthweight and Apgar score of the newborn." | 3.78 | Maternal caffeine intake and its effect on pregnancy outcomes. ( Jarosz, M; Siuba, M; Wierzejska, R, 2012) |
| "Moderate caffeine consumption (less than 200 mg per day) does not appear to be a major contributing factor in miscarriage or preterm birth." | 3.76 | ACOG CommitteeOpinion No. 462: Moderate caffeine consumption during pregnancy. ( , 2010) |
| " In comparison with not drinkers, all the ORs of overall intake of caffeine were closed near the unity for both SGA and NGA preterm birth." | 3.73 | Coffee drinking and risk of preterm birth. ( Chatenoud, L; Chiaffarino, F; Chiantera, V; Fedele, L; Maffioletti, C; Parazzini, F; Ricci, E; Tozzi, L, 2006) |
| "While the developed preterm model for the prediction of PK behaviour in preterm patients is not intended to replace clinical studies, it can potentially help with deciding on first-time dosing in this population and study design in the absence of clinical data." | 2.94 | Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population. ( Abduljalil, K; Jamei, M; Johnson, TN; Pan, X; Pansari, A, 2020) |
| "To compare two dosing regimens for caffeine citrate for neonates born less than 30 weeks gestation in terms of development, temperament and behaviour." | 2.76 | Caffeine citrate for very preterm infants: Effects on development, temperament and behaviour. ( Charles, BG; Flenady, VJ; Gray, PH; Steer, PA, 2011) |
| "Caffeine exposure was associated to SGA (OR = 1." | 1.51 | Caffeine exposure during pregnancy, small for gestational age birth and neonatal outcome - results from the Norwegian Mother and Child Cohort Study. ( Bellocco, R; Brantsæter, AL; Elfvin, A; Jacobsson, B; Meltzer, HM; Modzelewska, D; Sengpiel, V, 2019) |
| "Caffeine was prescribed for apnea of prematurity and caffeine exposure was determined by chart review." | 1.51 | Caffeine exposure and acute kidney injury in premature infants with necrotizing enterocolitis and spontaneous intestinal perforation. ( Aviles-Otero, N; Carmody, JB; Green, G; Khalsa, DD; Kumar, R, 2019) |
| "Caffeine intake was derived from coffee, tea, soft drinks, and cocoa-containing foods and beverages." | 1.48 | Associations of maternal caffeine intake with birth outcomes: results from the Lifeways Cross Generation Cohort Study. ( Chen, LW; Fitzgerald, R; Kelleher, CC; Mehegan, J; Murrin, CM; Phillips, CM, 2018) |
| "Caffeine intake was consistently associated with decreased BW and increased odds of SGA." | 1.39 | Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study. ( Alexander, J; Bacelis, J; Brantsaeter, AL; Elind, E; Grove, J; Haugen, M; Jacobsson, B; Meltzer, HM; Myhre, R; Nilsson, S; Sengpiel, V, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.03) | 29.6817 |
| 2010's | 22 (66.67) | 24.3611 |
| 2020's | 10 (30.30) | 2.80 |
| Authors | Studies |
|---|---|
| McPherson, C | 1 |
| Lean, RE | 1 |
| Cyr, PEP | 1 |
| Inder, TE | 1 |
| Rogers, CE | 1 |
| Smyser, CD | 1 |
| Giszas, V | 1 |
| Strauß, E | 1 |
| Bührer, C | 1 |
| Endesfelder, S | 1 |
| Bushman, ET | 1 |
| Blanchard, CT | 1 |
| Cozzi, GD | 1 |
| Davis, AM | 1 |
| Harper, L | 1 |
| Robbins, LS | 1 |
| Jones, B | 1 |
| Szychowski, JM | 1 |
| Digre, KB | 1 |
| Casey, BM | 1 |
| Tita, AT | 1 |
| Sinkey, RG | 1 |
| Abduljalil, K | 1 |
| Pan, X | 1 |
| Pansari, A | 1 |
| Jamei, M | 1 |
| Johnson, TN | 1 |
| Williams, EE | 1 |
| Hunt, KA | 1 |
| Jeyakara, J | 1 |
| Subba-Rao, R | 1 |
| Dassios, T | 1 |
| Greenough, A | 1 |
| Van der Veeken, L | 1 |
| Grönlund, S | 1 |
| Gerdtsson, E | 1 |
| Holmqvist, B | 1 |
| Deprest, J | 1 |
| Ley, D | 1 |
| Bruschettini, M | 1 |
| Chiu, HY | 1 |
| Chu, SM | 1 |
| Lin, HY | 1 |
| Tsai, ML | 1 |
| Chen, YT | 1 |
| Lin, HC | 1 |
| James, JE | 1 |
| Siahanidou, T | 1 |
| Spiliopoulou, C | 1 |
| Jensen, EA | 1 |
| Abdel Wahed, MA | 1 |
| Issa, HM | 1 |
| Khafagy, SM | 1 |
| Abdel Raouf, SM | 1 |
| Chen, LW | 1 |
| Fitzgerald, R | 1 |
| Murrin, CM | 1 |
| Mehegan, J | 1 |
| Kelleher, CC | 1 |
| Phillips, CM | 1 |
| Aviles-Otero, N | 1 |
| Kumar, R | 1 |
| Khalsa, DD | 1 |
| Green, G | 1 |
| Carmody, JB | 1 |
| Vitti, FP | 1 |
| Grandi, C | 1 |
| Cavalli, RC | 1 |
| Simões, VMF | 1 |
| Batista, RFL | 1 |
| Cardoso, VC | 1 |
| Modzelewska, D | 1 |
| Bellocco, R | 1 |
| Elfvin, A | 1 |
| Brantsæter, AL | 1 |
| Meltzer, HM | 2 |
| Jacobsson, B | 2 |
| Sengpiel, V | 2 |
| Kobayashi, S | 1 |
| Sata, F | 1 |
| Murata, K | 1 |
| Saijo, Y | 1 |
| Araki, A | 1 |
| Miyashita, C | 1 |
| Itoh, S | 1 |
| Minatoya, M | 1 |
| Yamazaki, K | 1 |
| Ait Bamai, Y | 1 |
| Kishi, R | 1 |
| Elind, E | 1 |
| Bacelis, J | 1 |
| Nilsson, S | 1 |
| Grove, J | 1 |
| Myhre, R | 1 |
| Haugen, M | 1 |
| Alexander, J | 1 |
| Brantsaeter, AL | 1 |
| Triche, EW | 1 |
| Lundsberg, LS | 1 |
| Hollins Martin, C | 1 |
| Greenwood, DC | 1 |
| Thatcher, NJ | 1 |
| Ye, J | 1 |
| Garrard, L | 1 |
| Keogh, G | 1 |
| King, LG | 1 |
| Cade, JE | 1 |
| Okubo, H | 1 |
| Miyake, Y | 1 |
| Tanaka, K | 1 |
| Sasaki, S | 1 |
| Hirota, Y | 1 |
| Jahanfar, S | 1 |
| Jaafar, SH | 1 |
| Del Castillo, N | 1 |
| Jiménez-Moleón, JJ | 1 |
| Olmedo-Requena, R | 1 |
| Martínez-Ruiz, V | 1 |
| Bueno-Cavanillas, A | 1 |
| Mozas, J | 1 |
| Katheria, A | 1 |
| Rich, W | 1 |
| Finer, N | 1 |
| Cabrera, OH | 1 |
| O'Connor, SD | 1 |
| Swiney, BS | 1 |
| Salinas-Contreras, P | 1 |
| Manzella, FM | 1 |
| Taylor, GT | 1 |
| Noguchi, KK | 1 |
| Gray, PH | 2 |
| Chauhan, M | 1 |
| Maslova, E | 1 |
| Bhattacharya, S | 1 |
| Lin, SW | 1 |
| Michels, KB | 1 |
| Flenady, VJ | 1 |
| Charles, BG | 1 |
| Steer, PA | 1 |
| Jarosz, M | 1 |
| Wierzejska, R | 1 |
| Siuba, M | 1 |
| Crossley, KJ | 1 |
| Allison, BJ | 1 |
| Polglase, GR | 1 |
| Morley, CJ | 1 |
| Harding, R | 1 |
| Davis, PG | 1 |
| Moss, TJ | 1 |
| Hooper, SB | 1 |
| Vavasseur, C | 1 |
| Chiaffarino, F | 1 |
| Parazzini, F | 1 |
| Chatenoud, L | 1 |
| Ricci, E | 1 |
| Tozzi, L | 1 |
| Chiantera, V | 1 |
| Maffioletti, C | 1 |
| Fedele, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacokinetics (PK) and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia[NCT05295784] | Phase 1 | 18 participants (Anticipated) | Interventional | 2024-06-30 | Not yet recruiting | ||
| Caffeine in the Second Stage: A Randomized Control Trial in Low-risk Nulliparous Mothers at Term[NCT05906303] | Phase 1 | 80 participants (Anticipated) | Interventional | 2023-12-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for caffeine and Preterm Birth
| Article | Year |
|---|---|
Evidence base multi-discipline critical strategies toward better tomorrow for very preterm infants.
Topics: Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Budesonide; Caffeine; Central Nervous System Stim | 2020 |
Maternal caffeine consumption and pregnancy outcomes: a narrative review with implications for advice to mothers and mothers-to-be.
Topics: Caffeine; Child; Female; Humans; Infant, Newborn; Mothers; Pregnancy; Pregnancy Outcome; Premature B | 2021 |
Pharmacological Neuroprotection of the Preterm Brain: Current Evidence and Perspectives.
Topics: Brain; Caffeine; Erythropoietin; Female; Humans; Infant, Newborn; Infant, Premature; Neuroprotection | 2022 |
What is bronchopulmonary dysplasia and does caffeine prevent it?
Topics: Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Rel | 2020 |
Caffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose-response meta-analysis.
Topics: Abortion, Spontaneous; Birth Weight; Caffeine; Female; Humans; Infant, Small for Gestational Age; Pr | 2014 |
Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes.
Topics: Birth Weight; Caffeine; Central Nervous System Stimulants; Coffee; Female; Humans; Infant, Newborn; | 2015 |
Optimizing Care of the Preterm Infant Starting in the Delivery Room.
Topics: Blood Pressure; Blood Transfusion; Caffeine; Central Nervous System Stimulants; Constriction; Delive | 2016 |
Caffeine consumption during pregnancy and risk of preterm birth: a meta-analysis.
Topics: Caffeine; Female; Humans; Obstetric Labor, Premature; Odds Ratio; Plant Preparations; Pregnancy; Pre | 2010 |
4 trials available for caffeine and Preterm Birth
| Article | Year |
|---|---|
Five-year outcomes of premature infants randomized to high or standard loading dose caffeine.
Topics: Caffeine; Child; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Dise | 2022 |
Occipital Nerve Block Compared With Acetaminophen and Caffeine for Headache Treatment in Pregnancy: A Randomized Controlled Trial.
Topics: Acetaminophen; Anesthetics, Local; Caffeine; Female; Headache; Humans; Infant, Newborn; Nerve Block; | 2023 |
Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population.
Topics: Administration, Intravenous; Administration, Oral; Alfentanil; Anti-Bacterial Agents; Caffeine; Comp | 2020 |
Caffeine citrate for very preterm infants: Effects on development, temperament and behaviour.
Topics: Australia; Caffeine; Central Nervous System Stimulants; Child Development; Citrates; Dose-Response R | 2011 |
21 other studies available for caffeine and Preterm Birth
| Article | Year |
|---|---|
The Conflicting Role of Caffeine Supplementation on Hyperoxia-Induced Injury on the Cerebellar Granular Cell Neurogenesis of Newborn Rats.
Topics: Animals; Animals, Newborn; Caffeine; Cerebellum; Dietary Supplements; Female; Humans; Hyperoxia; Inf | 2022 |
Electrical activity of the diaphragm following a loading dose of caffeine citrate in ventilated preterm infants.
Topics: Action Potentials; Age Factors; Airway Extubation; Caffeine; Citrates; Diaphragm; Electromyography; | 2020 |
Long-term neurological effects of neonatal caffeine treatment in a rabbit model of preterm birth.
Topics: Animals; Animals, Newborn; Astrocytes; Behavior, Animal; Brain; Caffeine; Central Nervous System Sti | 2020 |
Effect of caffeine on superior mesenteric artery blood flow velocities in preterm neonates.
Topics: Blood Flow Velocity; Caffeine; Citrates; Female; Gestational Age; Hemodynamics; Humans; Infant, Newb | 2019 |
Associations of maternal caffeine intake with birth outcomes: results from the Lifeways Cross Generation Cohort Study.
Topics: Adult; Alcohol Drinking; Birth Weight; Caffeine; Cigarette Smoking; Coffee; Cohort Studies; Diet; Fe | 2018 |
Caffeine exposure and acute kidney injury in premature infants with necrotizing enterocolitis and spontaneous intestinal perforation.
Topics: Acute Kidney Injury; Age Factors; Caffeine; Enterocolitis, Necrotizing; Female; Gestational Age; Hum | 2019 |
Association between Caffeine Consumption in Pregnancy and Low Birth Weight and Preterm Birth in the birth Cohort of Ribeirão Preto.
Topics: Adult; Brazil; Caffeine; Cohort Studies; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; | 2018 |
Caffeine exposure during pregnancy, small for gestational age birth and neonatal outcome - results from the Norwegian Mother and Child Cohort Study.
Topics: Adult; Birth Weight; Caffeine; Cohort Studies; Female; Gestational Age; Humans; Infant, Low Birth We | 2019 |
Dose-dependent associations between prenatal caffeine consumption and small for gestational age, preterm birth, and reduced birthweight in the Japan Environment and Children's Study.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female; Humans | 2019 |
Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study.
Topics: Adult; Birth Weight; Caffeine; Cohort Studies; Diet; Female; Humans; Norway; Pregnancy; Premature Bi | 2013 |
Caffeine is modestly associated with lower birth weight and fetal growth.
Topics: Birth Weight; Caffeine; Diet; Female; Humans; Pregnancy; Premature Birth | 2014 |
Higher coffee intake in pregnancy linked to prolonged gestation, and higher caffeine intake linked with babies being small for gestational age.
Topics: Birth Weight; Caffeine; Diet; Female; Humans; Pregnancy; Premature Birth | 2014 |
Maternal total caffeine intake, mainly from Japanese and Chinese tea, during pregnancy was associated with risk of preterm birth: the Osaka Maternal and Child Health Study.
Topics: Adult; Asian People; Body Mass Index; Caffeine; Carbonated Beverages; Child Health; Coffee; Diet; Fe | 2015 |
PERINATAL OUTCOMES OF PREMATURITY AND BIRTH WEIGHT ACCORDING TO MATERNAL CAFFEINE CONSUMPTION.
Topics: Adult; Birth Weight; Caffeine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Hu | 2015 |
Caffeine combined with sedative/anesthetic drugs triggers widespread neuroapoptosis in a mouse model of prematurity.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Caffeine; Disease Models, Animal; Female; Humans; | 2017 |
Use of caffeine for preterm infants in Australia and New Zealand: A survey.
Topics: Airway Extubation; Apnea; Caffeine; Health Care Surveys; Humans; Infant, Newborn; New Zealand; Pract | 2016 |
ACOG CommitteeOpinion No. 462: Moderate caffeine consumption during pregnancy.
Topics: Abortion, Spontaneous; Beverages; Caffeine; Female; Fetal Growth Retardation; Food; Humans; Pregnanc | 2010 |
Maternal caffeine intake and its effect on pregnancy outcomes.
Topics: Adolescent; Adult; Age Factors; Apgar Score; Beverages; Birth Weight; Caffeine; Female; Fetal Develo | 2012 |
Effects of caffeine on renal and pulmonary function in preterm newborn lambs.
Topics: Animals; Animals, Newborn; Caffeine; Ductus Arteriosus; Female; Gestational Age; Heart Rate; Infusio | 2012 |
Caffeine therapy in neonatal intensive care.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Child Development; Child, Preschool; Humans; Inf | 2012 |
Coffee drinking and risk of preterm birth.
Topics: Adolescent; Adult; Birth Weight; Caffeine; Case-Control Studies; Coffee; Female; Humans; Infant, New | 2006 |